[RGLS] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
04-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -0.00%
YoY- 5.59%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 6 6,778 18 18 489 4,200 1,631 -60.67%
PBT -5,945 -3,260 -16,024 -20,025 -21,212 -14,491 -12,740 -11.91%
Tax -8 56 1 -4 -5 -4 1 -
NP -5,937 -3,260 -16,025 -20,021 -21,207 -14,487 -12,741 -11.94%
Tax Rate - - - - - - - -
Total Cost 5,943 10,038 16,043 20,039 21,696 18,687 14,372 -13.67%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -98,950.00 -48.10 -89,027.78 -111,227.78 -4,336.81 -344.93 -781.18 123.93%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -2.47 -3.14 -18.49 -45.34 -48.28 -34.72 -35.81 -35.93%
EPS Diluted -2.47 -3.14 -18.49 -45.34 -48.28 -34.72 -35.81 -35.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.